| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_PDS5B_0029500 | Exon-Exon | chr13:33344792-33347462 | chr13:32770654-32773324 | 244 nt | 0.4303 |
| hsa_chr13_0122500 | Intergenic-Intergenic | chr13:33345505-33345707 | chr13:32771367-32771569 | 203 nt | 0.3547 |
| hsa_PDS5B_0029700 | Intron-Intron | chr13:33346801-33346991 | chr13:32772663-32772853 | 191 nt | 0.3770 |
| hsa_PDS5B_0029800 | Intron-Exon | chr13:33347596-33349196 | chr13:32773458-32775058 | 1601 nt | 0.3554 |
A study in humans identified circPDS5B as a biomarker positively correlated with infarct volume in acute ischemic stroke patients [Wei et al. DOI:10.1186/s12883-021-02397-0]. A study in humans demonstrated that hsa_circRNA_0004494, a circular RNA, was significantly downregulated in peripheral blood mononuclear cells from heart failure patients with sacubitril/valsartan resistance compared to non-resistant patients following acute myocardial infarction, as validated by quantitative real-time PCR in 18 sample pairs [Su et al. DOI:10.1016/j.ejphar.2023.175547].